Content
02/23/2024
Pittsburgh, PA USA
Abridge
completed $150 million Series C Round funding. Investors include
Lightspeed Venture Partners (lead), Redpoint Ventures (lead), Spark Capital, Bessemer Venture Partners, Union Square Ventures, CVS Health Ventures, Wittington Ventures, IVP, Mass General Brigham Ventures, Kaiser Permanente Ventures.
About
Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. Our AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients.
Our enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time, with deep EMR integrations. Powered by Linked Evidence and our purpose-built, auditable AI, we are the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output. As pioneers in generative AI for healthcare, we are setting the industry standards for the responsible deployment of AI across health systems.
Startup
Sector:
Healthcare
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
